Target intelligence / Profile preview

Hemagglutinin protein stalk region (HA stalk) (HA stalk)

Target
HA stalk
Molecular classification
Viral surface glycoprotein, Class I fusion protein, Type I transmembrane protein
01

Overview

The H5N1 influenza virus hemagglutinin (HA) protein stalk region is a highly conserved domain of the primary surface glycoprotein of the influenza A virus [1, 6]. While the globular head of the HA protein frequently mutates to evade the immune system, the stalk region remains relatively stable across diverse influenza subtypes, making it a critical target for universal vaccine development and broadly neutralizing antibodies (bnAbs) [2, 17]. Biologically, the stalk region facilitates the fusion of the viral envelope with the host cell's endosomal membrane, a process essential for the release of the viral genome into the cytoplasm [6, 20]. This fusion is triggered by the low-pH environment of the endosome, which causes the stalk to undergo a dramatic conformational rearrangement [3, 6]. Therapeutic agents, including bnAbs like MEDI8852 and small molecules like IY7640, target this region to lock the HA protein in its pre-fusion state, thereby neutralizing the virus [5, 12, 14]. Because the stalk is naturally immunosubdominant, current research focuses on innovative vaccine strategies, such as chimeric or headless HAs, to elicit a robust protective response against this conserved site [11, 17]. Targeting the HA stalk is considered a promising approach to provide broad protection against both seasonal and pandemic-potential strains like H5N1 [1, 12].

Other names
HA stemHA stalkHA2 subunitConserved stem domainHemagglutinin stem regionH5N1 HA stalk
02

Mechanism of action

Inhibition of the pH-induced conformational change of the hemagglutinin protein, which prevents the fusion of the viral envelope with the host endosomal membrane and blocks the release of the viral genome into the host cell cytoplasm [1, 6, 14].

03

Biological functions

Viral entryMembrane fusionViral-endosomal membrane fusion
04

Disease associations

InfectionInfluenza A (H5N1)Avian influenzaPandemic influenza
05

Safety considerations

Immunosubdominance (low natural immunogenicity)Potential for viral escape mutationsTheoretical risk of antibody-dependent enhancement (ADE)
06

Interacting drugs

CR6261

9 more in the full profile.

07

Biomarkers

Anti-HA stalk antibody titersStalk-specific neutralizing antibody levels

Beyond the preview

Go deeper on Hemagglutinin protein stalk region (HA stalk) (HA stalk).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin protein stalk region (HA stalk) (HA stalk).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call